These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35274187)

  • 1. Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.
    Adusumilli P; Elsayed N; Theophanous S; Samuel R; Cooper R; Casanova N; Tolan DJ; Gilbert A; Scarsbrook AF
    Eur Radiol; 2022 Aug; 32(8):5086-5096. PubMed ID: 35274187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
    Brown PJ; Zhong J; Frood R; Currie S; Gilbert A; Appelt AL; Sebag-Montefiore D; Scarsbrook A
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2790-2799. PubMed ID: 31482428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort.
    Zhong J; Sundersingh M; Dyker K; Currie S; Vaidyanathan S; Prestwich R; Scarsbrook A
    Sci Rep; 2020 Mar; 10(1):4086. PubMed ID: 32139722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
    Duimering A; Riauka T; Nijjar Y; Ghosh S; MacEwan R; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Nijjar T; Fairchild A; Mulder K; Doll C; Wong C; Joseph K
    Radiother Oncol; 2019 Jul; 136():21-28. PubMed ID: 31015125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Training and external validation of pre-treatment FDG PET-CT-based models for outcome prediction in anal squamous cell carcinoma.
    Frood R; Mercer J; Brown P; Appelt A; Mistry H; Kochhar R; Scarsbrook A
    Eur Radiol; 2024 May; 34(5):3194-3204. PubMed ID: 37924344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Patient Outcomes in Locally Advanced Cervical Carcinoma Following Chemoradiotherapy-Comparative Effectiveness of Magnetic Resonance Imaging and 2-Deoxy-2-[
    Dhesi SS; Frood R; Swift S; Cooper R; Muzumdar S; Jamal M; Scarsbrook A
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of
    Houard C; Pinaquy JB; Mesguich C; Henriques de Figueiredo B; Cazeau AL; Allard JB; Laharie H; Bordenave L; Fernandez P; Vendrely V
    J Nucl Med; 2017 Sep; 58(9):1414-1420. PubMed ID: 28280225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre- and post-treatment FDG PET-CT as a predictor of patient outcomes in anal squamous cell carcinoma: A systematic review and meta-analysis.
    Mac Curtain BM; Qian W; Bell J; O'Mahony A; Temperly HC; Ng ZQ
    J Med Imaging Radiat Oncol; 2023 Sep; 67(6):634-646. PubMed ID: 37573606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.
    Kochhar R; Renehan AG; Mullan D; Chakrabarty B; Saunders MP; Carrington BM
    Eur Radiol; 2017 Feb; 27(2):607-617. PubMed ID: 27090113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
    Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
    Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy.
    Scarsbrook A; Vaidyanathan S; Chowdhury F; Swift S; Cooper R; Patel C
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):581-588. PubMed ID: 27738729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of
    Combet-Curt V; Buchalet C; Le Malicot K; Lemanski C; Deshayes E; Bonichon-Lamichhane N; Lièvre A; Huguet F; Tlili G; Vendrely V
    J Nucl Med; 2024 Aug; 65(8):1194-1201. PubMed ID: 38936973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma.
    Filippi L; Fontana A; Spinelli GP; Rossi L; Bagni O
    Nucl Med Commun; 2020 Oct; 41(10):1089-1094. PubMed ID: 32732599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
    Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI morphological characteristics of lymph nodes in anal squamous cell carcinoma.
    Gulevski S; Frennered A; Trägårdh E; Nilsson MP; Johnsson A; Buchwald P; Blomqvist L; Zackrisson S
    Abdom Radiol (NY); 2024 Apr; 49(4):1042-1050. PubMed ID: 38319345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Rosen BS; Wilkie JR; Sun Y; Ibrahim M; Casper KA; Miller JE; Chotchutipan T; Stucken CL; Bradford C; Prince MEP; Rosko AJ; Malloy KM; McLean SA; Chinn SB; Shuman AG; Spector ME; Swiecicki PL; Worden FP; Shah JL; Schonewolf CA; Chapman CH; Eisbruch A; Mierzwa ML
    Radiother Oncol; 2021 Feb; 155():174-181. PubMed ID: 33069764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and Clinical Impact of Persistent Disease Diagnosed on Diffusion-Weighted Imaging and Accuracy of Pelvic Nodal Assessment on Magnetic Resonance Imaging for Squamous Cell Carcinoma of the Anus in the 6-Month Interval Post Chemoradiotherapy.
    Fernandes MC; Charbel C; Romesser PB; Ucpinar BA; Homsi ME; Yildirim O; Fuqua JL; Rodriguez LA; Zheng J; Capanu M; Gollub MJ; Horvat N
    Int J Radiat Oncol Biol Phys; 2024 Sep; 120(1):120-129. PubMed ID: 38462017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
    Schouten CS; de Graaf P; Alberts FM; Hoekstra OS; Comans EF; Bloemena E; Witte BI; Sanchez E; Leemans CR; Castelijns JA; de Bree R
    Oral Oncol; 2015 May; 51(5):541-7. PubMed ID: 25725587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Accuracy of
    Murtojärvi S; Malaspina S; Kinnunen I; Tuokkola T; Honka MJ; Saunavaara V; Tolvanen T; Schrey A; Kemppainen J
    Contrast Media Mol Imaging; 2022; 2022():8676787. PubMed ID: 36082064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.